Patients were excluded from the study if they suffered a fracture prior to the SOT procedure, were operated on after 72 hours from emergency department admission, or did not sustain a lower-extremity fracture. The initial CPT query returned 94 patients, of which we excluded 58.
There were 36 patients (at least 18 years old) that met our criteria and sustained an emergent fracture in the time after having an SOT procedure.
One patient suffered a lower-extremity fracture and then suffered another lower-extremity fracture more than 90 days later. We recorded this 
Results
Out of the 36 patients, 20 were male and 16 were female. Thirty-three individuals were white, 2 were black, and 1 was Asian. There were 31 femur fractures (83%), 3 tibia fractures (8%), 1 lateral malleolus fracture (3%), 1 trimalleolar fracture (3%), and 1 event with multiple fractures (3%). Out of the 37 fracture events, the most common comorbidities were hypertension at 65% (24/37), diabetes mellitus at 43% (16/37), and hyperlipidemia at 43% (16/37).
The median age at transplant was 53 with a range of 12 to 71, and the median age at fracture was 61 with a range of 20 to 78. The 90-day mortality rate following emergent repair of a lower-extremity fracture (13/37), and anemia at 32.4% (12/37) ( Table 1 ).
Conclusion
The results show that SOT patients have com- This study was limited by its retrospective design and by patients being drawn from a single institution, as well as its small sample size.
Another limitation of this study was the inability to draw comparisons between our cohort and non-SOT patients. This limitation meant that we could only provide descriptive statistics about our SOT cohort. The future publication from this work will include a comprehensive report of our findings, including an examination of the relationships between predictor variables and outcomes in the SOT cohort. In conclusion, SOT patients frequently have medical complications within the 90 days following emergent fracture surgery, possibly due to immunosuppression or comorbidities. We recommend close follow-up for at least 90 days with a high index of suspicion for acute kidney injury and transfusion requirements in this cohort.
